Cargando…

Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442146/
https://www.ncbi.nlm.nih.gov/pubmed/30860337
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0734
_version_ 1783407657020817408
collection PubMed
description
format Online
Article
Text
id pubmed-6442146
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-64421462019-04-05 Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet Int Braz J Urol Editorial Sociedade Brasileira de Urologia 2019 /pmc/articles/PMC6442146/ /pubmed/30860337 http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0734 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title_full Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title_fullStr Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title_full_unstemmed Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title_short Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
title_sort are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? not yet
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442146/
https://www.ncbi.nlm.nih.gov/pubmed/30860337
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0734